Loading...
OTCM
PHBI
Market cap530kUSD
Aug 01, Last price  
0.00USD
1D
-6.98%
1Q
-38.46%
IPO
-99.97%
Name

Pharmagreen Biotech Inc

Chart & Performance

D1W1MN
P/E
—
P/S
155.69
EPS
—
Div Yield, %
—
Shrs. gr., 5y
54.85%
Rev. gr., 5y
%
Revenues
3k
+13.74%
000000002,9983,410
Net income
-1m
L+76.59%
-1,669-69,682-18,986-1,073,581-890,387-3,324,615-5,538,989-633,990-568,775-1,004,399
CFO
-28k
L-61.96%
-1,669-61,107-21,081-785,534-317,832-607,634-206,081-426,568-73,838-28,086

Profile

Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.
URL
https://www.pharmagreen.ca
IPO date
Dec 12, 2008
Employees
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑09
Income
Revenues
3
13.74%
3
 
Cost of revenue
251
470
1,070
Unusual Expense (Income)
NOPBT
(248)
(467)
(1,070)
NOPBT Margin
Operating Taxes
(242)
Tax Rate
NOPAT
(248)
(467)
(828)
Net income
(1,004)
76.59%
(569)
-10.29%
(634)
-88.55%
Dividends
Dividend yield
Proceeds from repurchase of equity
187
BB yield
Debt
Debt current
266
282
219
Long-term debt
91
91
119
Deferred revenue
Other long-term liabilities
(119)
Net debt
356
283
331
Cash flow
Cash from operating activities
(28)
(74)
(427)
CAPEX
Cash from investing activities
Cash from financing activities
29
83
314
FCF
722
(53)
(767)
Balance
Cash
276
1
8
Long term investments
89
Excess cash
106
90
8
Stockholders' equity
(13,455)
(12,541)
(12,086)
Invested Capital
10,677
10,733
10,601
ROIC
ROCE
8.91%
25.80%
72.08%
EV
Common stock shares outstanding
659,369
466,532
403,733
Price
Market cap
EV
EBITDA
(248)
(467)
(1,070)
EV/EBITDA
Interest
121
47
Interest/NOPBT